Targeting CDC7 potentiates ATR-CHK1 signaling inhibition through induction of DNA replication stress in liver cancer

Overview of attention for article published in Genome Medicine, October 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

patent: 2 patents

Readers on

mendeley: 24 Mendeley

Summary X Patents

So far, Altmetric has seen 2 patents that reference this research output.

COMBINATION THERAPY FOR CANCER COMPRISING A CDC7 INHIBITOR AND A CDK8 INIHIBITOR OR A…

Application EP-4275686-A1

European Patent Office

COMBINATION OF CISPLATIN AND ELIMUSERTIB FOR THE TREATMENT OF PEDIATRIC LIVER CANCERS

Application WO-2023118062-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.